Navigation Links
Test allows early detection of vision problems in infants with hemangiomas of eyelids
Date:4/1/2009

Philadelphia, 1 April 2009 In children with vascular birthmarks around the eye, even partial blockage of vision can lead to visual loss due to amblyopia. Now a simple test can detect early evidence of amblyopia in infants too young for conventional vision testing, reports a study in the April issue of the American Journal of Ophthalmology (http://www.elsevier.com/locate/ajo) published by Elsevier.

Led by Dr. William V. Good of Smith-Kettlewell Eye Research Institute, San Francisco, the researchers performed the early vision test in four infants with vascular birthmarks, or hemangiomas, on the upper or lower eyelids. These birthmarks generally resolve over time without treatment. However, if they are blocking part of the field of vision in the affected eye, they can lead to permanent reductions in vision, called amblyopia.

The test, called "sweep visual evoked potential vernier acuity," works by monitoring brain responses to changes in the alignment of two lines. None of the four infants had had any clinical evidence of amblyopia.

However, the vernier acuity measurements identified early visual abnormalities in the eyes with birthmarks. Brainwave responses to the shifting lines were significantly reduced in the eyes affected by hemangiomas, compared to the fellow eyes.

Vascular birthmarks occurring in the area around the eye have the potential to cause significant vision loss before the abnormality resolves, or before the child is old enough for conventional vision testing. Dr. Good commented, "Many congenital ocular or eyelid abnormalities present physicians with a management conundrum: Is treatment for potential amblyopia necessary?"

The new results show that vernier visual acuity measurements are a promising tool for early detection of "amblyopia-like effects" in children with eyelid hemangiomas, who can then be targeted for treatment. "This study has implications for the management of children with intermittent occlusion, who may develop amblyopia even when the clinical assessment is negative," added Dr. Good. "It is likely that these findings extend to other eyelid problems, including congenital ptosis [drooping eyelid], where amblyopia may be present even in the absence of clinical features for amblyopia."


'/>"/>

Contact: Maureen Hunter
m.hunter@elsevier.com
215-239-3671
Elsevier
Source:Eurekalert

Related medicine news :

1. Donation of $15,000 and Hard Work Allows a Family in Need to Move into New Home
2. Microgrid allows simultaneous study of multiple variables
3. Computer simulator allows visually-impaired to drive
4. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
5. Anesthesia Pouch Allows Children to Go Home Sooner After Surgery
6. A new method allows for the early diagnosis of pulmonary hypertension
7. Mapping tool allows emergency management personnel to visually track resources
8. Elseviers "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights
9. Elseviers WiserWiki allows physicians to update evidence-based medical information
10. U.S. Patent Office Allows Significant New VNUS Patent
11. U.S. Patent Office Allows Another Significant VNUS Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University ... academic faculty engaged in or interested in palliative care education and research. The Symposium, ... held in North County San Diego on Sept. 28 and 29, 2017, on the ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management ... radiology marketing programs at the annual Building Better Radiology Marketing Programs conference, ... Hotel in Fort Worth, Texas. Nine awards are given out in five categories. They ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
(Date:2/23/2017)... ... 2017 , ... Rare Disease Report®, which is the only ... Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on February ... e-newsletter and quarterly publication, will be conducting interviews with patients and advocates in ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a national ... marketing, social media management, corporate communications, SEO and cause marketing, is opening an ... nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
(Date:2/23/2017)... -- ... Research and Markets has announced the addition of the "Global Antifungal ... to their offering. The Global Antifungal Drugs Market is ... decade to reach approximately $12.8 billion by 2025. ... given segments on global as well as regional levels presented in the ...
(Date:2/23/2017)... 2017  MiMedx Group, Inc. (NASDAQ: MDXG), the leading ... processes to develop and market advanced products and therapies ... Ophthalmic, and Dental sectors of healthcare, today announced its ... ended December 31, 2016. Full Year 2016 ... 31% increase over full year 2015 revenue ...
Breaking Medicine Technology: